Oncology Information Systems Market Overview:
To a recent research report by Market Research Community, the oncology information systems market is expected to surpass USD 5.18 Billion by the year 2030, from USD 2.70 Billion in 2021.
A comprehensive information and image management tool called an oncology information system (OIS) makes it easier to manage and improve the therapy and patient profiles of cancer patients. OIS software is used in healthcare facilities like clinics, hospitals, and research labs to manage patient portfolios.
Top Key Players of the Oncology Information Systems Market:
Elekta AB; Accuray Inc.; Varian Medical Systems; RaySearch Laboratories; Cerner Corp.; BrainLab; Philips Healthcare; Prowess, Inc.; DOSIsoft S.A.; ViewRay Inc.; MIM Software and Flatiron, McKesson Corporation, Siemens Medical Solutions Inc.
On the Basis of Product:
Solutions (Patient Information Systems, Treatment Planning Systems) Professional Services
On the Basis of Application:
By End User:
Hospitals & Diagnostic Imaging Centers
Ablation Care Centers and Cancer Care Centers
North America– (U.S., Canada, Mexico)
Europe- (Germany, France, U.K., Russia, Italy, Spain, BENELUX, Rest of Europe)
Asia Pacific- (China, Japan, India, South Korea, Australia, ASEAN, Rest of Asia Pacific)
Latin America- (Brazil, Argentina, Chile, Rest of Latin America)
Middle East and Africa- (GCC, Turkey, Israel, Rest of MEA)
During the forecast period, the surgical oncology market is anticipated to expand significantly. Over the years, cancer treatment has advanced quickly. For the majority of solid cancers, surgery is no longer the preferred therapeutic option; instead, it is combined with multi-modal therapies, primarily radiation, targeted molecular therapies, and chemotherapy. Some operations, including sarcoma surgery, laparoscopic cancer surgery, isolated limb perfusion, and cytoreductive surgery, can be carried out in hospitals with a high level of specialist medical care. As a result, the market is anticipated to rise as surgical therapies for solid tumors become more difficult.
OIS is in great demand, and Asian nations are steadily emerging as a result of government policies that are favorable to this market and growing public understanding of the advantages of these systems. Further, other regions such as the Middle East and Africa, Latin America, and Europe are expected to boost the market expansion during the forecast period.
The oncology information systems market is projected to grow at a significant pace reaching a CAGR of approximately 7.5%, over the forecast period of 2022–2030, despite a considerable fall in Product sales during the initial phase of pandemic spread and lockdown restrictions imposed globally.
The study is consolidated into major segments and further into sub-segments, such as by Product (Solutions, Professional Services ), by application (Medical Oncology, Radiation Oncology, Surgical Oncology), End-Use (Hospitals & Diagnostic Imaging Centers, Ablation Care Centers, and Cancer Care Centers, Government Institutions, Research Facilities) to forecast the oncology information systems market size by value; also includes the analysis of past market dynamics from 2016 – 2021, considering 2021 as the base year.
The research provides answers to the following key questions:
- What is the expected growth rate of the Oncology Information Systems Market? What will be the market size for the forecast period, 2022 – 2030?
- What are the major driving forces responsible for transforming the trajectory of the industry?
- Who are major vendors dominating the Oncology Information Systems industry across different regions? What are their winning strategies to stay ahead in the competition?
- What are the market trends business owners can rely upon in the coming years?
- What are the threats and challenges expected to restrict the progress of the industry across different countries?
- What are the key opportunities that business owners can bank on for the forecast period, 2022 – 2030?
Our Recently Published Report:
Market Research Community